Gait M J, Karn J
MRC Laboratory of Molecular Biology, Cambridge, UK.
Trends Biochem Sci. 1993 Jul;18(7):255-9. doi: 10.1016/0968-0004(93)90176-n.
The human immunodeficiency virus (HIV-1) regulatory proteins, Tat and Rev, are important potential targets for the development of new drug therapies against HIV infection. Both proteins are highly specific RNA-binding proteins that recognize cis-acting regulatory elements in the viral mRNAs. These interactions are fascinating paradigms of a new principle of RNA recognition in which the protein makes contact with functional groups displayed in a distorted major groove of an RNA duplex.
人类免疫缺陷病毒1型(HIV-1)调节蛋白Tat和Rev是开发抗HIV感染新药疗法的重要潜在靶点。这两种蛋白都是高度特异性的RNA结合蛋白,可识别病毒mRNA中的顺式作用调节元件。这些相互作用是RNA识别新原理的迷人范例,即蛋白质与RNA双链体扭曲的大沟中展示的官能团发生接触。